Business
BNCM Announces the Expansion of DELEX PHARMA’s Medical Device Business
BNCM Announces the Expansion of DELEX PHARMA’s Medical Device Business.
About this update from Bounce Mobile Systems, Inc.
[{"type":"text","content":"9th September 2024 – BNCM announces today the expansion of DELEX PHARMA’s medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the company’s total revenue, reinforcing DELEX’s rapid growth in the healthcare sector.Philippine Medical Device Market on the RiseThe Philippine medical device market is experiencing substantial growth, driven by increasing demand for advanced imaging technologies. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.14% from 2024 to 2029, reaching a market volume of USD 1.036 billion by 2029, according to Statista.Augmenting Fluid Management and Patient Care SolutionsThe fluid management market in the Philippines is growing due to increasing healthcare needs, rising prevalence of chronic diseases, and advancements in medical technology. The market size and growth in the Philippines is projected to reach approximately USD100 million by 2025, growing at a CAGR of around 8% from 2023 to 2025, according to MarketsandMarkets.Hence, DELEX has also partnered with Amsino, a California-based global leader in fluid management, medication delivery, and patient care solutions. Amsino’s FDA-qualified facilities and 25 years of expertise bring a range of innovative products to the Philippine market through DELEX PHARMA. Amsino Products includes the Suction and Fluid Management (Receptal Trolleys & Liners, Receptal Canisters, iReceptal): Suction and fluid management play a critical role in healthcare, particularly in settings such as hospitals and clinics where effective management of bodily fluids is essential for patient care.Diversifying in Medical Imaging and OR SolutionsThe medical device market in the Philippines for 2024 is valued at approximately USD670 million and is expected to grow at a CAGR of around 8.4% from 2024 to 2029, according to Statista. To propel market development, DELEX PHARMA has further strengthened its portfolio by partnering with SternMed GmbH, a German company specializing in high-quality medical devices and turnkey healthcare solutions. This partnership includes:OR Solutions (Surgical light, Surgical table, Anesthesia Unit Electrosurgical Unit): OR solutions are vital in Philippine healthcare for enhancing s...